Impact of SARS CoV2 on post-hospital recovery of carbohydrate and muscle metabolism: role of endothelial injury
Impact of SARS CoV2 on post-hospital recovery of carbohydrate and muscle metabolism: role of endothelial injury
批准号:
10686353
负责人:
IVOR Samuel DOUGLAS
金额:
$35.12万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-15 至 2024-08-31
关键词:
2019-nCoVAddressArchitectureBeta CellBlood VesselsBlood capillariesBlood flowCOVID-19COVID-19 impactCOVID-19 mortalityCOVID-19 susceptibilityCarbohydratesCardiovascular DiseasesComplications of Diabetes MellitusContinuous Glucose MonitorDataDiabetes MellitusDiffuseEndotheliumFatigueFunctional disorderFutureGlucoseGoalsHospitalizationHospitalsHyperglycemiaHypertensionImpairmentInfectionInjuryInpatientsInsulinInsulin ResistanceIntervention StudiesIslets of LangerhansMeasuresMediatingMicrocirculationMicrovascular DysfunctionModelingMuscleMuscle MitochondriaMuscle WeaknessMuscle functionOGTTObesityOrganOutpatientsPerfusionPersonsQuestionnairesRecoveryRehabilitation therapyReportingRoleSARS-CoV-2 infectionSepsisSkeletal MuscleSpecific qualifier valueStressTestingTherapeuticThrombusTimecarbohydrate metabolismcomorbidityendothelial dysfunctionexperimental studyfrailtyfunctional statusin vivoinsulin secretionintravital microscopyisletlong term consequences of COVID-19mathematical modelmortality riskmultidisciplinarymuscle metabolismnovelpost-COVID-19primary endpointrehabilitation strategysecondary analysissevere COVID-19skeletal muscle metabolismtype I and type II diabetesvascular injury
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
This proposal tests the novel hypothesis that pre-existing diabetes (or new stress hyperglycemia), exacerbates
the systemic impact of COVID-19-mediated microvascular injury and slows recovery via persistence of
hyperglycemia and diabetes related persistent endothelial injury. Our long-term goal is to understand the
post-infection consequences of COVID-19 infection on carbohydrate metabolism and diabetes
complications. Decreased effective perfusion of the islets and skeletal muscle may contribute to the post-
infection sequelae of COVID-19 infection such as decreased insulin secretion and insulin action and fatigue.
The goal of this proposal is to examine the short-term impact of COVID-19 infection on post-
hospitalization carbohydrate and skeletal muscle metabolism, and to test the correlation of
hyperglycemia and diffuse endothelial injury with these late endpoints.
Hypothesis: COVID-19 deleteriously impacts carbohydrate metabolism and skeletal muscle function
due to systemic perfusion abnormalities, worse in diabetes; post-hospitalization recovery of these
parameters will be slowed in the context of hyperglycemia and endothelial injury.
SA#1: Test the hypothesis that COVID-19 impairs insulin secretion and action and that post-
hospitalization recovery is slowed in the context of persistent hyperglycemia and/or diffuse endothelial
injury. The relative contribution of decreased insulin secretion versus systemic insulin resistance to COVID-19
mediated hyperglycemia is unknown, as are the factors contributing to dysglycemia. Studies under this aim will
evaluate the relationship of diffuse endothelial injury and dysglycemia to carbohydrate metabolism in people
with and without diabetes post-hospitalization using an oral glucose tolerance test.
SA# 2: Test the hypothesis that dysglycemia and diffuse endothelial injury slow skeletal muscle
recovery post COVID-19. No data exist on post COVID-19 functional status recovery or skeletal muscle
function comparing people with and without diabetes. These experiments will examine post-hospitalization
muscle oxidative flux, insulin action and perfusion and explore the correlation of these parameters, glucose
profiles and endothelial injury in people with and without diabetes post COVID-19 hospitalization.
Impact: Successful execution of the proposed studies will provide new information on recovery from COVID-
19 with regards to carbohydrate metabolism and frailty. These data may inform post-hospitalization glycemic
management to lessen the long-term consequences of COVID-19 in people with diabetes.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2337/dc23-0089
发表时间:
2023-10-01
期刊:
DIABETES CARE
影响因子:
16.2
作者:
[Finn, Erin, Schlichting, Lindsay, Grau, Laura, Douglas, Ivor S., Pereira, Rocio I.]
通讯作者:
Pereira, Rocio I.
Angiogenesis in hyperoxic lung fibrosis
-
批准号:6807021
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2003
-
负责人:IVOR Samuel DOUGLAS
-
依托单位:
Angiogenesis in hyperoxic lung fibrosis
-
批准号:6945428
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2003
-
负责人:IVOR Samuel DOUGLAS
-
依托单位:
Angiogenesis in hyperoxic lung fibrosis
-
批准号:7116881
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2003
-
负责人:IVOR Samuel DOUGLAS
-
依托单位:
Angiogenesis in hyperoxic lung fibrosis
-
批准号:6605174
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2003
-
负责人:IVOR Samuel DOUGLAS
-
依托单位:
Angiogenesis in hyperoxic lung fibrosis
-
批准号:7280865
-
项目类别:
-
资助金额:$12.62万
-
财政年份:2003
-
负责人:IVOR Samuel DOUGLAS
-
依托单位:
海外基金